iShares · 2001-02-05 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$443.5M | — | — | $9.09B | 每日估算 |
| 2026-07-30 | +$122.5M | — | — | $9.46B | 每日估算 |
| 2026-07-29 | -$43.0M | — | — | $9.44B | 每日估算 |
| 2026-07-28 | +$272.7M | — | — | $9.37B | 每日估算 |
| 2026-07-27 | +$40.4M | — | — | $9.09B |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
BlackRock Cash Funds: Institutional, SL Agency Shares BlackRock Cash Funds: Institutional, SL Agency Shares | STIV | 784,655,767 | $784.8M | 9.66% |
Gilead Sciences, Inc. Gilead Sciences, Inc. | EC | 4,515,707 | $629.4M | 7.75% |
Amgen, Inc. Amgen, Inc. | EC | 1,733,148 | $609.8M | 7.51% |
Vertex Pharmaceuticals, Inc. |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified、category_reclassified_by_current_taxonomy。
| 每日估算 |
| 2026-07-26 | -$328.9M | — | — | $9.09B | 每日估算 |
| 2026-07-25 | +$42.0M | — | — | $9.46B | 每日估算 |
| 2026-03-31 | -$332.0M | $942.1M | $1.27B | $8.12B | SEC 月度 |
| 2026-02-28 | +$102.1M | $1.21B | $1.11B | — | SEC 月度 |
| 2026-01-31 | +$21.3M | $829.2M | $807.8M | — | SEC 月度 |
| EC |
| 1,354,033 |
| $604.6M |
| 7.44% |
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. | EC | 758,232 | $585.8M | 7.21% |
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. | EC | 979,642 | $324.1M | 3.99% |
Insmed, Inc. Insmed, Inc. | EC | 1,587,887 | $259.7M | 3.20% |
Argenx SE Argenx SE | EC | 341,883 | $249.7M | 3.07% |
Biogen, Inc. Biogen, Inc. | EC | 1,091,046 | $200.0M | 2.46% |
Natera, Inc. Natera, Inc. | EC | 980,622 | $196.1M | 2.41% |
United Therapeutics Corp. United Therapeutics Corp. | EC | 315,509 | $187.1M | 2.30% |
BeOne Medicines Ltd. BeOne Medicines Ltd. | EC | 529,143 | $157.1M | 1.93% |
Incyte Corp. Incyte Corp. | EC | 1,467,923 | $138.2M | 1.70% |
Moderna, Inc. Moderna, Inc. | EC | 2,692,459 | $136.8M | 1.68% |
Illumina, Inc. Illumina, Inc. | EC | 1,107,291 | $136.5M | 1.68% |
Revolution Medicines, Inc. Revolution Medicines, Inc. | EC | 1,283,912 | $124.9M | 1.54% |
Roivant Sciences Ltd. Roivant Sciences Ltd. | EC | 3,642,557 | $100.9M | 1.24% |
Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. | EC | 727,502 | $95.8M | 1.18% |
Genmab A/S Genmab A/S | EC | 3,555,098 | $95.4M | 1.17% |
Bridgebio Pharma, Inc. Bridgebio Pharma, Inc. | EC | 1,238,687 | $92.0M | 1.13% |
Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc. | EC | 1,205,549 | $90.5M | 1.11% |
Medpace Holdings, Inc. Medpace Holdings, Inc. | EC | 169,922 | $81.6M | 1.00% |
Madrigal Pharmaceuticals, Inc. Madrigal Pharmaceuticals, Inc. | EC | 155,341 | $81.3M | 1.00% |
Exelixis, Inc. Exelixis, Inc. | EC | 1,871,326 | $80.3M | 0.99% |
BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc. | EC | 1,412,330 | $79.8M | 0.98% |
Ascendis Pharma A/S Ascendis Pharma A/S | EC | 339,948 | $77.8M | 0.96% |
Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc. | EC | 195,097 | $62.9M | 0.77% |
Charles River Laboratories International, Inc. Charles River Laboratories International, Inc. | EC | 362,165 | $62.5M | 0.77% |
Arrowhead Pharmaceuticals, Inc. Arrowhead Pharmaceuticals, Inc. | EC | 975,175 | $61.1M | 0.75% |
Vaxcyte, Inc. Vaxcyte, Inc. | EC | 1,045,695 | $60.8M | 0.75% |
Bio-Techne Corp. Bio-Techne Corp. | EC | 1,151,950 | $60.2M | 0.74% |
Cytokinetics, Inc. Cytokinetics, Inc. | EC | 896,972 | $59.1M | 0.73% |
Halozyme Therapeutics, Inc. Halozyme Therapeutics, Inc. | EC | 868,502 | $56.1M | 0.69% |
Axsome Therapeutics, Inc. Axsome Therapeutics, Inc. | EC | 319,088 | $53.9M | 0.66% |
BioNTech SE BioNTech SE | EC | 599,506 | $53.3M | 0.66% |
Krystal Biotech, Inc. Krystal Biotech, Inc. | EC | 188,966 | $48.8M | 0.60% |
Protagonist Therapeutics, Inc. Protagonist Therapeutics, Inc. | EC | 447,047 | $47.1M | 0.58% |
Repligen Corp. Repligen Corp. | EC | 396,896 | $46.8M | 0.58% |
Kymera Therapeutics, Inc. Kymera Therapeutics, Inc. | EC | 521,385 | $43.4M | 0.53% |
Alkermes plc Alkermes plc | EC | 1,216,662 | $43.0M | 0.53% |
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals, Inc. | EC | 474,539 | $41.3M | 0.51% |
Abivax SA Abivax SA | EC | 367,461 | $40.9M | 0.50% |
PTC Therapeutics, Inc. PTC Therapeutics, Inc. | EC | 593,152 | $40.4M | 0.50% |
Cogent Biosciences, Inc. Cogent Biosciences, Inc. | EC | 1,009,396 | $38.9M | 0.48% |
Arcellx, Inc. Arcellx, Inc. | EC | 335,814 | $38.6M | 0.47% |
Terns Pharmaceuticals, Inc. Terns Pharmaceuticals, Inc. | EC | 713,848 | $37.6M | 0.46% |
Nuvalent, Inc., Class A Nuvalent, Inc., Class A | EC | 355,481 | $36.4M | 0.45% |
Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. | EC | 392,677 | $36.3M | 0.45% |
Tempus AI, Inc., Class A Tempus AI, Inc., Class A | EC | 773,906 | $35.0M | 0.43% |
Xenon Pharmaceuticals, Inc. Xenon Pharmaceuticals, Inc. | EC | 598,390 | $34.8M | 0.43% |
Amicus Therapeutics, Inc. Amicus Therapeutics, Inc. | EC | 2,307,725 | $33.4M | 0.41% |
CRISPR Therapeutics AG CRISPR Therapeutics AG | EC | 663,733 | $31.6M | 0.39% |
Apellis Pharmaceuticals, Inc. Apellis Pharmaceuticals, Inc. | EC | 778,245 | $31.3M | 0.39% |
Apogee Therapeutics, Inc. Apogee Therapeutics, Inc. | EC | 353,520 | $29.8M | 0.37% |
Scholar Rock Holding Corp. Scholar Rock Holding Corp. | EC | 593,730 | $29.2M | 0.36% |
ACADIA Pharmaceuticals, Inc. ACADIA Pharmaceuticals, Inc. | EC | 1,251,241 | $27.9M | 0.34% |
Bruker Corp. Bruker Corp. | EC | 764,342 | $27.6M | 0.34% |
Crinetics Pharmaceuticals, Inc. Crinetics Pharmaceuticals, Inc. | EC | 726,428 | $26.4M | 0.32% |
CG oncology, Inc. CG oncology, Inc. | EC | 379,295 | $25.7M | 0.32% |
Spyre Therapeutics, Inc. Spyre Therapeutics, Inc. | EC | 478,909 | $24.2M | 0.30% |
Erasca, Inc. Erasca, Inc. | EC | 1,384,399 | $22.4M | 0.28% |
Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc. | EC | 297,522 | $20.9M | 0.26% |
Twist Bioscience Corp. Twist Bioscience Corp. | EC | 436,795 | $20.8M | 0.26% |
Centessa Pharmaceuticals plc Centessa Pharmaceuticals plc | EC | 520,762 | $20.7M | 0.25% |
Ideaya Biosciences, Inc. Ideaya Biosciences, Inc. | EC | 615,636 | $20.5M | 0.25% |
Denali Therapeutics, Inc. Denali Therapeutics, Inc. | EC | 1,055,210 | $20.3M | 0.25% |
Travere Therapeutics, Inc. Travere Therapeutics, Inc. | EC | 674,600 | $20.0M | 0.25% |
ImmunityBio, Inc. ImmunityBio, Inc. | EC | 2,572,701 | $19.7M | 0.24% |
Arcutis Biotherapeutics, Inc. Arcutis Biotherapeutics, Inc. | EC | 814,779 | $19.2M | 0.24% |
Veracyte, Inc. Veracyte, Inc. | EC | 579,343 | $18.7M | 0.23% |
Structure Therapeutics, Inc. Structure Therapeutics, Inc. | EC | 381,676 | $18.4M | 0.23% |
Edgewise Therapeutics, Inc. Edgewise Therapeutics, Inc. | EC | 572,192 | $18.0M | 0.22% |
10X Genomics, Inc., Class A 10X Genomics, Inc., Class A | EC | 841,716 | $17.9M | 0.22% |
Legend Biotech Corp. Legend Biotech Corp. | EC | 983,928 | $17.8M | 0.22% |
Newamsterdam Pharma Co. NV Newamsterdam Pharma Co. NV | EC | 537,784 | $17.2M | 0.21% |
Vera Therapeutics, Inc., Class A Vera Therapeutics, Inc., Class A | EC | 419,778 | $16.9M | 0.21% |
Dyne Therapeutics, Inc. Dyne Therapeutics, Inc. | EC | 917,470 | $16.6M | 0.20% |
Beam Therapeutics, Inc. Beam Therapeutics, Inc. | EC | 692,124 | $16.5M | 0.20% |
BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals, Inc. | EC | 1,715,826 | $16.3M | 0.20% |
Kodiak Sciences, Inc. Kodiak Sciences, Inc. | EC | 422,431 | $16.1M | 0.20% |
Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. | EC | 739,607 | $16.1M | 0.20% |
Caris Life Sciences, Inc. Caris Life Sciences, Inc. | EC | 898,011 | $16.1M | 0.20% |
Immunovant, Inc. Immunovant, Inc. | EC | 626,211 | $15.6M | 0.19% |
ADMA Biologics, Inc. ADMA Biologics, Inc. | EC | 1,711,239 | $15.4M | 0.19% |
Adaptive Biotechnologies Corp. Adaptive Biotechnologies Corp. | EC | 1,105,997 | $15.4M | 0.19% |
Summit Therapeutics, Inc. Summit Therapeutics, Inc. | EC | 799,477 | $15.2M | 0.19% |
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc. | EC | 304,331 | $14.9M | 0.18% |
Syndax Pharmaceuticals, Inc. Syndax Pharmaceuticals, Inc. | EC | 631,524 | $14.8M | 0.18% |
Tango Therapeutics, Inc. Tango Therapeutics, Inc. | EC | 687,885 | $14.4M | 0.18% |
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. | EC | 680,286 | $14.3M | 0.18% |
Disc Medicine, Inc. Disc Medicine, Inc. | EC | 214,889 | $13.7M | 0.17% |
Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. | EC | 400,087 | $13.5M | 0.17% |
GRAIL, Inc. GRAIL, Inc. | EC | 261,045 | $13.5M | 0.17% |
Definium Therapeutics, Inc. Definium Therapeutics, Inc. | EC | 703,030 | $13.3M | 0.16% |
Zymeworks, Inc. Zymeworks, Inc. | EC | 529,981 | $13.3M | 0.16% |
Arcus Biosciences, Inc. Arcus Biosciences, Inc. | EC | 612,355 | $13.2M | 0.16% |
BlackRock Cash Funds: Treasury, SL Agency Shares BlackRock Cash Funds: Treasury, SL Agency Shares | STIV | 12,996,156 | $13.0M | 0.16% |
Aurinia Pharmaceuticals, Inc. Aurinia Pharmaceuticals, Inc. | EC | 874,336 | $13.0M | 0.16% |
Enliven Therapeutics, Inc. Enliven Therapeutics, Inc. | EC | 322,556 | $12.6M | 0.16% |
Day One Biopharmaceuticals, Inc. Day One Biopharmaceuticals, Inc. | EC | 578,773 | $12.4M | 0.15% |
Vericel Corp. Vericel Corp. | EC | 373,502 | $12.0M | 0.15% |
Mineralys Therapeutics, Inc. Mineralys Therapeutics, Inc. | EC | 439,648 | $11.9M | 0.15% |
Alumis, Inc. Alumis, Inc. | EC | 530,358 | $11.7M | 0.14% |
Zai Lab Ltd. Zai Lab Ltd. | EC | 613,747 | $11.5M | 0.14% |
Nurix Therapeutics, Inc. Nurix Therapeutics, Inc. | EC | 720,848 | $11.2M | 0.14% |
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. | EC | 331,288 | $10.8M | 0.13% |
Intellia Therapeutics, Inc. Intellia Therapeutics, Inc. | EC | 835,337 | $10.7M | 0.13% |
AnaptysBio, Inc. AnaptysBio, Inc. | EC | 192,136 | $10.7M | 0.13% |
Recursion Pharmaceuticals, Inc., Class A Recursion Pharmaceuticals, Inc., Class A | EC | 3,419,857 | $10.5M | 0.13% |
Tyra Biosciences, Inc. Tyra Biosciences, Inc. | EC | 272,474 | $10.4M | 0.13% |
Relay Therapeutics, Inc. Relay Therapeutics, Inc. | EC | 980,266 | $9.8M | 0.12% |
Amylyx Pharmaceuticals, Inc. Amylyx Pharmaceuticals, Inc. | EC | 687,536 | $9.6M | 0.12% |
Novavax, Inc. Novavax, Inc. | EC | 1,157,114 | $9.4M | 0.12% |
Iovance Biotherapeutics, Inc. Iovance Biotherapeutics, Inc. | EC | 2,619,021 | $9.2M | 0.11% |
WaVe Life Sciences Ltd. WaVe Life Sciences Ltd. | EC | 1,176,186 | $8.5M | 0.10% |
Immunocore Holdings plc Immunocore Holdings plc | EC | 277,185 | $8.4M | 0.10% |
Novocure Ltd. Novocure Ltd. | EC | 763,201 | $8.3M | 0.10% |
Galapagos NV Galapagos NV | EC | 271,893 | $8.2M | 0.10% |
Grifols SA Grifols SA | EC | 976,161 | $7.8M | 0.10% |
Biohaven Ltd. Biohaven Ltd. | EC | 917,535 | $7.8M | 0.10% |
Nuvation Bio, Inc., Class A Nuvation Bio, Inc., Class A | EC | 1,795,888 | $7.7M | 0.09% |
AtaiBeckley, Inc. AtaiBeckley, Inc. | EC | 2,160,067 | $7.6M | 0.09% |
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc. | EC | 1,672,180 | $7.5M | 0.09% |
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. | EC | 185,101 | $7.4M | 0.09% |
Trevi Therapeutics, Inc. Trevi Therapeutics, Inc. | EC | 608,481 | $7.3M | 0.09% |
Mesoblast Ltd. Mesoblast Ltd. | EC | 460,143 | $7.1M | 0.09% |
Corvus Pharmaceuticals, Inc. Corvus Pharmaceuticals, Inc. | EC | 473,326 | $6.9M | 0.09% |
Olema Pharmaceuticals, Inc. Olema Pharmaceuticals, Inc. | EC | 457,751 | $6.8M | 0.08% |
Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. | EC | 217,759 | $6.8M | 0.08% |
uniQure NV uniQure NV | EC | 413,699 | $6.8M | 0.08% |
Geron Corp. Geron Corp. | EC | 4,513,103 | $6.7M | 0.08% |
Fortrea Holdings, Inc. Fortrea Holdings, Inc. | EC | 693,057 | $6.5M | 0.08% |
Vir Biotechnology, Inc. Vir Biotechnology, Inc. | EC | 704,449 | $6.3M | 0.08% |
Xencor, Inc. Xencor, Inc. | EC | 513,267 | $6.2M | 0.08% |
AbCellera Biologics, Inc. AbCellera Biologics, Inc. | EC | 1,732,022 | $6.0M | 0.07% |
MBX Biosciences, Inc. MBX Biosciences, Inc. | EC | 199,599 | $6.0M | 0.07% |
Maze Therapeutics, Inc. Maze Therapeutics, Inc. | EC | 197,936 | $5.9M | 0.07% |
CareDx, Inc. CareDx, Inc. | EC | 337,886 | $5.9M | 0.07% |
Theravance Biopharma, Inc. Theravance Biopharma, Inc. | EC | 353,652 | $5.7M | 0.07% |
Monte Rosa Therapeutics, Inc. Monte Rosa Therapeutics, Inc. | EC | 346,430 | $5.7M | 0.07% |
KalVista Pharmaceuticals, Inc. KalVista Pharmaceuticals, Inc. | EC | 276,916 | $5.6M | 0.07% |
Janux Therapeutics, Inc. Janux Therapeutics, Inc. | EC | 392,349 | $5.5M | 0.07% |
Pharvaris NV Pharvaris NV | EC | 191,961 | $5.4M | 0.07% |
MannKind Corp. MannKind Corp. | EC | 2,199,381 | $5.4M | 0.07% |
ORIC Pharmaceuticals, Inc. ORIC Pharmaceuticals, Inc. | EC | 424,422 | $5.4M | 0.07% |
Castle Biosciences, Inc. Castle Biosciences, Inc. | EC | 215,689 | $5.3M | 0.07% |
Annexon, Inc. Annexon, Inc. | EC | 952,884 | $5.3M | 0.06% |
UroGen Pharma Ltd. UroGen Pharma Ltd. | EC | 286,041 | $5.1M | 0.06% |
Kura Oncology, Inc. Kura Oncology, Inc. | EC | 628,449 | $5.1M | 0.06% |
Inhibrx Biosciences, Inc. Inhibrx Biosciences, Inc. | EC | 75,835 | $5.1M | 0.06% |
Stevanato Group SpA Stevanato Group SpA | EC | 370,391 | $5.1M | 0.06% |
Arbutus Biopharma Corp. Arbutus Biopharma Corp. | EC | 1,119,437 | $5.0M | 0.06% |
Septerna, Inc. Septerna, Inc. | EC | 200,845 | $4.8M | 0.06% |
Alto Neuroscience, Inc. Alto Neuroscience, Inc. | EC | 212,677 | $4.8M | 0.06% |
Bicara Therapeutics, Inc. Bicara Therapeutics, Inc. | EC | 236,865 | $4.7M | 0.06% |
GH Research plc GH Research plc | EC | 334,162 | $4.7M | 0.06% |
ArriVent Biopharma, Inc. ArriVent Biopharma, Inc. | EC | 201,242 | $4.6M | 0.06% |
CytomX Therapeutics, Inc. CytomX Therapeutics, Inc. | EC | 987,397 | $4.6M | 0.06% |
Cullinan Therapeutics, Inc. Cullinan Therapeutics, Inc. | EC | 323,429 | $4.6M | 0.06% |
Replimune Group, Inc. Replimune Group, Inc. | EC | 570,930 | $4.4M | 0.05% |
Precigen, Inc. Precigen, Inc. | EC | 1,104,713 | $4.3M | 0.05% |
Arvinas, Inc. Arvinas, Inc. | EC | 403,100 | $4.3M | 0.05% |
Savara, Inc. Savara, Inc. | EC | 775,563 | $4.2M | 0.05% |
Ironwood Pharmaceuticals, Inc., Class A Ironwood Pharmaceuticals, Inc., Class A | EC | 1,173,471 | $4.1M | 0.05% |
Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals, Inc. | EC | 356,945 | $4.0M | 0.05% |
Zevra Therapeutics, Inc. Zevra Therapeutics, Inc. | EC | 413,742 | $3.9M | 0.05% |
Cytek Biosciences, Inc. Cytek Biosciences, Inc. | EC | 868,726 | $3.8M | 0.05% |
MeiraGTx Holdings plc MeiraGTx Holdings plc | EC | 430,643 | $3.7M | 0.05% |
ARS Pharmaceuticals, Inc. ARS Pharmaceuticals, Inc. | EC | 463,404 | $3.7M | 0.05% |
BioAge Labs, Inc. BioAge Labs, Inc. | EC | 211,362 | $3.7M | 0.05% |
Sana Biotechnology, Inc. Sana Biotechnology, Inc. | EC | 1,235,916 | $3.6M | 0.04% |
Rigel Pharmaceuticals, Inc. Rigel Pharmaceuticals, Inc. | EC | 131,031 | $3.5M | 0.04% |
Zenas Biopharma, Inc. Zenas Biopharma, Inc. | EC | 175,941 | $3.4M | 0.04% |
Compass Pathways plc Compass Pathways plc | EC | 612,150 | $3.4M | 0.04% |
Fulcrum Therapeutics, Inc. Fulcrum Therapeutics, Inc. | EC | 429,371 | $3.3M | 0.04% |
OPKO Health, Inc. OPKO Health, Inc. | EC | 2,882,600 | $3.3M | 0.04% |
Solid Biosciences, Inc. Solid Biosciences, Inc. | EC | 446,552 | $3.2M | 0.04% |
4D Molecular Therapeutics, Inc. 4D Molecular Therapeutics, Inc. | EC | 338,744 | $3.2M | 0.04% |
Prothena Corp. plc Prothena Corp. plc | EC | 323,349 | $3.1M | 0.04% |
Emergent BioSolutions, Inc. Emergent BioSolutions, Inc. | EC | 376,503 | $3.1M | 0.04% |
Myriad Genetics, Inc. Myriad Genetics, Inc. | EC | 662,895 | $3.0M | 0.04% |
Absci Corp. Absci Corp. | EC | 975,088 | $2.9M | 0.04% |
BridgeBio Oncology Therapeutics, Inc. BridgeBio Oncology Therapeutics, Inc. | EC | 324,513 | $2.9M | 0.04% |
Perspective Therapeutics, Inc. Perspective Therapeutics, Inc. | EC | 693,460 | $2.9M | 0.04% |
Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. | EC | 766,012 | $2.9M | 0.04% |
Altimmune, Inc. Altimmune, Inc. | EC | 926,610 | $2.9M | 0.04% |
Vanda Pharmaceuticals, Inc. Vanda Pharmaceuticals, Inc. | EC | 405,038 | $2.8M | 0.03% |
Allogene Therapeutics, Inc. Allogene Therapeutics, Inc. | EC | 1,145,572 | $2.8M | 0.03% |
REGENXBIO, Inc. REGENXBIO, Inc. | EC | 331,423 | $2.8M | 0.03% |
Rocket Pharmaceuticals, Inc. Rocket Pharmaceuticals, Inc. | EC | 752,567 | $2.7M | 0.03% |
Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc. | EC | 2,021,533 | $2.7M | 0.03% |
Lexeo Therapeutics, Inc. Lexeo Therapeutics, Inc. | EC | 457,447 | $2.6M | 0.03% |
Alvotech SA Alvotech SA | EC | 763,481 | $2.6M | 0.03% |
Contineum Therapeutics, Inc., Class A Contineum Therapeutics, Inc., Class A | EC | 200,362 | $2.6M | 0.03% |
Enanta Pharmaceuticals, Inc. Enanta Pharmaceuticals, Inc. | EC | 205,184 | $2.6M | 0.03% |
Lineage Cell Therapeutics, Inc. Lineage Cell Therapeutics, Inc. | EC | 1,621,430 | $2.6M | 0.03% |
Standard BioTools, Inc. Standard BioTools, Inc. | EC | 2,747,556 | $2.5M | 0.03% |
ADC Therapeutics SA ADC Therapeutics SA | EC | 673,142 | $2.5M | 0.03% |
Design Therapeutics, Inc. Design Therapeutics, Inc. | EC | 235,859 | $2.5M | 0.03% |
Personalis, Inc. Personalis, Inc. | EC | 393,153 | $2.5M | 0.03% |
Atea Pharmaceuticals, Inc. Atea Pharmaceuticals, Inc. | EC | 460,056 | $2.5M | 0.03% |
Prime Medicine, Inc. Prime Medicine, Inc. | EC | 704,092 | $2.5M | 0.03% |
Keros Therapeutics, Inc. Keros Therapeutics, Inc. | EC | 214,789 | $2.4M | 0.03% |
Fulgent Genetics, Inc. Fulgent Genetics, Inc. | EC | 148,748 | $2.4M | 0.03% |
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc. | EC | 75,889 | $2.3M | 0.03% |
Aura Biosciences, Inc. Aura Biosciences, Inc. | EC | 338,128 | $2.3M | 0.03% |
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc. | EC | 251,263 | $2.2M | 0.03% |
Maravai LifeSciences Holdings, Inc., Class A Maravai LifeSciences Holdings, Inc., Class A | EC | 759,052 | $2.1M | 0.03% |
Immuneering Corp., Class A Immuneering Corp., Class A | EC | 390,008 | $2.1M | 0.03% |
Anavex Life Sciences Corp. Anavex Life Sciences Corp. | EC | 668,447 | $2.1M | 0.03% |
Entrada Therapeutics, Inc. Entrada Therapeutics, Inc. | EC | 158,267 | $2.0M | 0.02% |
Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Holdings, Inc. | EC | 317,323 | $1.9M | 0.02% |
Upstream Bio, Inc. Upstream Bio, Inc. | EC | 213,032 | $1.9M | 0.02% |
Neurogene, Inc. Neurogene, Inc. | EC | 94,694 | $1.9M | 0.02% |
LENZ Therapeutics, Inc. LENZ Therapeutics, Inc. | EC | 206,971 | $1.9M | 0.02% |
Autolus Therapeutics plc Autolus Therapeutics plc | EC | 1,321,681 | $1.8M | 0.02% |
Editas Medicine, Inc. Editas Medicine, Inc. | EC | 731,163 | $1.8M | 0.02% |
Cabaletta Bio, Inc. Cabaletta Bio, Inc. | EC | 633,353 | $1.7M | 0.02% |
C4 Therapeutics, Inc. C4 Therapeutics, Inc. | EC | 608,839 | $1.6M | 0.02% |
Larimar Therapeutics, Inc. Larimar Therapeutics, Inc. | EC | 350,415 | $1.6M | 0.02% |
Candel Therapeutics, Inc. Candel Therapeutics, Inc. | EC | 294,995 | $1.4M | 0.02% |
Arcturus Therapeutics Holdings, Inc. Arcturus Therapeutics Holdings, Inc. | EC | 186,967 | $1.4M | 0.02% |
OmniAb, Inc. OmniAb, Inc. | EC | 874,147 | $1.4M | 0.02% |
NovaBridge Biosciences NovaBridge Biosciences | EC | 539,518 | $1.3M | 0.02% |
Voyager Therapeutics, Inc. Voyager Therapeutics, Inc. | EC | 329,043 | $1.3M | 0.02% |
AC Immune SA AC Immune SA | EC | 443,438 | $1.2M | 0.02% |
Bicycle Therapeutics plc Bicycle Therapeutics plc | EC | 244,101 | $1.1M | 0.01% |
Caribou Biosciences, Inc. Caribou Biosciences, Inc. | EC | 594,484 | $1.1M | 0.01% |
Codexis, Inc. Codexis, Inc. | EC | 683,417 | $1.1M | 0.01% |
Lyell Immunopharma, Inc. Lyell Immunopharma, Inc. | EC | 54,413 | $1.1M | 0.01% |
Cellectis SA Cellectis SA | EC | 339,873 | $1.1M | 0.01% |
Foghorn Therapeutics, Inc. Foghorn Therapeutics, Inc. | EC | 223,190 | $1.1M | 0.01% |
Quanterix Corp. Quanterix Corp. | EC | 284,827 | $1.0M | 0.01% |
Sagimet Biosciences, Inc., Class A Sagimet Biosciences, Inc., Class A | EC | 189,187 | $988,502 | 0.01% |
Quantum-Si, Inc. Quantum-Si, Inc. | EC | 1,223,534 | $947,015 | 0.01% |
Silence Therapeutics plc Silence Therapeutics plc | EC | 173,313 | $913,360 | 0.01% |
Tenaya Therapeutics, Inc. Tenaya Therapeutics, Inc. | EC | 1,200,002 | $830,881 | 0.01% |
Neumora Therapeutics, Inc. Neumora Therapeutics, Inc. | EC | 421,430 | $821,789 | 0.01% |
PepGen, Inc. PepGen, Inc. | EC | 451,333 | $798,859 | 0.01% |
Humacyte, Inc. Humacyte, Inc. | EC | 1,222,120 | $741,460 | 0.01% |
Black Diamond Therapeutics, Inc. Black Diamond Therapeutics, Inc. | EC | 321,542 | $684,884 | 0.01% |
Pyxis Oncology, Inc. Pyxis Oncology, Inc. | EC | 345,130 | $503,890 | 0.01% |
Gossamer Bio, Inc. Gossamer Bio, Inc. | EC | 1,510,536 | $496,211 | 0.01% |
Jyong Biotech Ltd. Jyong Biotech Ltd. | EC | 206,499 | $443,973 | 0.01% |
Akero Therapeutics, Inc., CVR Akero Therapeutics, Inc., CVR | OTHER | 515,954 | $340,530 | 0.00% |
Aardvark Therapeutics, Inc. Aardvark Therapeutics, Inc. | EC | 89,682 | $338,101 | 0.00% |
Immutep Ltd. Immutep Ltd. | EC | 809,244 | $284,045 | 0.00% |
Alpha Teknova, Inc. Alpha Teknova, Inc. | EC | 79,636 | $230,148 | 0.00% |
Russell 2000 E-Mini Index Russell 2000 E-Mini Index | DE | 33 | $56,477 | 0.00% |
Contra Chinook Therape, CVR Contra Chinook Therape, CVR | OTHER | 320,962 | $54,564 | 0.00% |